• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从异常脑电波到改变的可塑性:注意缺陷多动障碍神经生物学领域中定量脑电图生物标志物与神经反馈的综述

From Aberrant Brainwaves to Altered Plasticity: A Review of QEEG Biomarkers and Neurofeedback in the Neurobiological Landscape of ADHD.

作者信息

Kopańska Marta, Trojniak Julia

机构信息

Department of Medical Psychology, Faculty of Medicine, University of Rzeszów, 35-959 Rzeszów, Poland.

Student Research Club "Reh-Tech", Faculty of Medicine, University of Rzeszów, 35-959 Rzeszów, Poland.

出版信息

Cells. 2025 Aug 29;14(17):1339. doi: 10.3390/cells14171339.

DOI:10.3390/cells14171339
PMID:40940749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12428149/
Abstract

This critical review synthesizes findings from quantitative electroencephalography (QEEG) to bridge the gap between systems-level neurophysiology and the underlying cellular pathology of Attention-Deficit/Hyperactivity Disorder (ADHD). As a prevalent neurodevelopmental disorder, ADHD diagnosis is challenged by symptomatic heterogeneity, creating an urgent need for objective biological indicators. Analysis of QEEG data reveals consistent neurophysiological patterns in ADHD, primarily an excess of Theta-band activity and a deficit in Beta-band activity. These findings have led to the proposal of specific biomarkers, such as the Theta/Beta Ratio (TBR), and serve as the basis for neurofeedback interventions aimed at modulating brainwave activity. While not a standalone diagnostic tool, this review posits that QEEG-based biomarkers and Neurofeedback responses are systems-level manifestations of putative cellular and synaptic dysfunctions. By outlining these robust macro-scale patterns, this work provides a conceptual framework intended to guide future molecular and cellular research into the fundamental biology of ADHD.

摘要

这篇批判性综述综合了定量脑电图(QEEG)的研究结果,以弥合系统水平神经生理学与注意力缺陷多动障碍(ADHD)潜在细胞病理学之间的差距。作为一种普遍的神经发育障碍,ADHD的诊断因症状异质性而面临挑战,迫切需要客观的生物学指标。对QEEG数据的分析揭示了ADHD中一致的神经生理模式,主要是θ波段活动过多和β波段活动不足。这些发现导致了特定生物标志物的提出,如θ/β比值(TBR),并为旨在调节脑电波活动的神经反馈干预提供了基础。虽然不是独立的诊断工具,但这篇综述认为基于QEEG的生物标志物和神经反馈反应是假定的细胞和突触功能障碍的系统水平表现。通过概述这些稳健的宏观尺度模式,这项工作提供了一个概念框架,旨在指导未来对ADHD基础生物学的分子和细胞研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a05/12428149/3460da6203e6/cells-14-01339-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a05/12428149/134c897e6e9e/cells-14-01339-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a05/12428149/5774869860c5/cells-14-01339-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a05/12428149/68c2b6926c37/cells-14-01339-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a05/12428149/3460da6203e6/cells-14-01339-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a05/12428149/134c897e6e9e/cells-14-01339-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a05/12428149/5774869860c5/cells-14-01339-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a05/12428149/68c2b6926c37/cells-14-01339-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a05/12428149/3460da6203e6/cells-14-01339-g004.jpg

相似文献

1
From Aberrant Brainwaves to Altered Plasticity: A Review of QEEG Biomarkers and Neurofeedback in the Neurobiological Landscape of ADHD.从异常脑电波到改变的可塑性:注意缺陷多动障碍神经生物学领域中定量脑电图生物标志物与神经反馈的综述
Cells. 2025 Aug 29;14(17):1339. doi: 10.3390/cells14171339.
2
Neurofeedback for ADHD: Exploring the Role of Quantitative EEG and Brainwave Modulation.注意力缺陷多动障碍的神经反馈:探索定量脑电图和脑电波调制的作用。
Brain Behav. 2025 Aug;15(8):e70714. doi: 10.1002/brb3.70714.
3
EEG-Guided Adaptive Learning: A New Neuroeducational Approach to the Facilitation of Cognitive Control in ADHD Children.脑电图引导的适应性学习:一种促进多动症儿童认知控制的新神经教育方法。
Child Care Health Dev. 2025 Jul;51(4):e70113. doi: 10.1111/cch.70113.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.针对5至18岁儿童注意力缺陷多动障碍(ADHD)的家长培训干预措施。
Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003018. doi: 10.1002/14651858.CD003018.pub3.
6
Short-Term Memory Impairment短期记忆障碍
7
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯——非随机研究中不良事件的评估
Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2.
8
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2.
9
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.安非他酮用于治疗成人注意力缺陷多动障碍(ADHD)。
Cochrane Database Syst Rev. 2017 Oct 2;10(10):CD009504. doi: 10.1002/14651858.CD009504.pub2.
10
ESCAschool study: trial protocol of an adaptive treatment approach for school-age children with ADHD including two randomised trials.欧洲心脏病学会学校研究:一项针对多动症学龄儿童的适应性治疗方法的试验方案,包括两项随机试验。
BMC Psychiatry. 2017 Jul 24;17(1):269. doi: 10.1186/s12888-017-1433-9.

本文引用的文献

1
Evaluating attention deficit and hyperactivity disorder (ADHD): a review of current methods and issues.评估注意力缺陷多动障碍(ADHD):当前方法与问题综述
Front Psychol. 2025 Feb 24;16:1466088. doi: 10.3389/fpsyg.2025.1466088. eCollection 2025.
2
The role of quantitative electroencephalography in diagnostic workup of mental disorders.定量脑电图在精神障碍诊断中的作用。
J Physiol Pharmacol. 2024 Aug;75(4). doi: 10.26402/jpp.2024.4.02. Epub 2024 Oct 10.
3
Bioinformatic Evaluation of Genetic Variant: Implications for Neurodevelopmental and Psychiatric Symptoms.
遗传变异的生物信息学评估:对神经发育和精神症状的影响。
Genes (Basel). 2024 Aug 11;15(8):1056. doi: 10.3390/genes15081056.
4
Identifying Risk Factors for Attention-Deficit/Hyperactivity Disorder (ADHD): a Public Health Concern and Opportunity.识别注意力缺陷多动障碍(ADHD)的风险因素:公共卫生关注和机会。
Prev Sci. 2024 May;25(Suppl 2):195-202. doi: 10.1007/s11121-024-01667-w. Epub 2024 Apr 10.
5
Integrated use of biofeedback and neurofeedback techniques in treating pathological conditions and improving performance: a narrative review.生物反馈和神经反馈技术在治疗病理状况及提高表现中的综合应用:一项叙述性综述
Front Neurosci. 2024 Mar 19;18:1358481. doi: 10.3389/fnins.2024.1358481. eCollection 2024.
6
Clinical efficacy of neurofeedback protocols in treatment of Attention Deficit/Hyperactivity Disorder (ADHD): A systematic review.神经反馈协议治疗注意缺陷多动障碍(ADHD)的临床疗效:系统评价。
Psychiatry Res Neuroimaging. 2023 Oct;335:111723. doi: 10.1016/j.pscychresns.2023.111723. Epub 2023 Oct 11.
7
An overview on neurobiology and therapeutics of attention-deficit/hyperactivity disorder.注意缺陷多动障碍的神经生物学与治疗学概述
Discov Ment Health. 2023 Jan 5;3(1):2. doi: 10.1007/s44192-022-00030-1.
8
Molecular Mechanisms Underlying NMDARs Dysfunction and Their Role in ADHD Pathogenesis.NMDARs 功能障碍的分子机制及其在 ADHD 发病机制中的作用。
Int J Mol Sci. 2023 Aug 19;24(16):12983. doi: 10.3390/ijms241612983.
9
The global prevalence of ADHD in children and adolescents: a systematic review and meta-analysis.儿童和青少年注意缺陷多动障碍的全球患病率:系统评价和荟萃分析。
Ital J Pediatr. 2023 Apr 20;49(1):48. doi: 10.1186/s13052-023-01456-1.
10
ADHD in the DSM-5-TR: What has changed and what has not.《精神疾病诊断与统计手册》第五版修订版(DSM-5-TR)中的注意缺陷多动障碍:有哪些变化,哪些未变。
Front Psychiatry. 2023 Jan 10;13:1064141. doi: 10.3389/fpsyt.2022.1064141. eCollection 2022.